In a groundbreaking achievement for pediatric heart care, the FDA has expanded the labeling of Johnson & Johnson MedTech’s Impella Support System to include treatment for certain children suffering from heart failure, extending the original approval for care of adults with heart failure.
Poster Session 5:40 –7:00 PM PST | Friday, November 15th Impact of LVAD Support with Impella 5.5 to Bridge Adolescents to Heart Transplant – An Evolving Strategy Cihangir Buyukgoz,
Abstract We report the largest pediatric multicenter experience with Impella pump use and peripheral veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support. Utilizing the Advanced Cardiac Therapies Improving Outcomes Network (ACTION) collaborative
Check out the newest One Page Summary (OPS) featuring the Abiomed Impella® This OPS includes an overview of the device size selection, system components, pump settings, waveforms, as well as highlighting anticoagulation,
Abiomed Impella® OPS Read More »
“Characteristics and Outcomes of Patients Supported with Impella Percutaneous VAD Device at Pediatric Institutions: Action Collaborative Experience” SEBASTIAN TUME, ET AL Download the Abstract
"*" indicates required fields
Copyright © 2024 Advanced Cardiac Therapies Improving Outcomes Network
